New baby formula with breast milk sugars studied for safety and growth
NCT ID NCT07302477
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new infant formula containing human milk oligosaccharides (HMOs), which are natural sugars found in breast milk, in 125 healthy full-term babies. The goal was to see if the formula supports normal growth and is easy for babies to digest in everyday, real-world conditions. Researchers measured weight, length, head size, and digestive comfort over 8 weeks. The study did not compare the formula to any other feeding method, so it provides early information on how well babies tolerate HMO-supplemented formula outside of a controlled lab setting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- infant formula supplemented with human milk oligosaccharides (HMOs) and Bifidobacterium lactis
- What this could lead to
- If successful, this could show that HMO-supplemented formula is a safe and well-tolerated option for healthy infants, potentially supporting normal growth and digestive health.
- What could go wrong
- This is a small, uncontrolled study without a comparison group, so results may not be conclusive. It only looks at short-term outcomes over 8 weeks, and any benefits seen might not hold up in larger, more rigorous trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVERSE EVENT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fatima Memorial Hospital
Lahore, Pakistan
-
Khawaja Muhammad Safdar Medical College
Sialkot, Pakistan
-
Liaqat National Hospital
Karachi, Pakistan
-
Quaid E Azam Medical College
Chak Four Hundred Fifty-four, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could KP405 offer a new way to tackle Parkinson's?
- Learning from mistakes: a new study maps patient safety in team-based primary care
- Which method best catches hospital errors? study puts four to the test
- Could colonoscopy prep become a pill instead of a gallon of liquid?
- Biopsy tolerance study ends early – what we know
- Which sedation is safer for TAVR? propofol vs dexmedetomidine